Previous 10 | Next 10 |
4Q Revenue of $805.5 million; 6% reported growth; 5% organic growth 4Q GAAP EPS from continuing operations of $0.58; Adjusted EPS of $1.35 4Q GAAP operating income margin of 17.2%; Adjusted operating income margin from continuing operations of 23.9% Initiates FY20 GAAP E...
PerkinElmer (NYSE: PKI ) is scheduled to announce Q4 earnings results on Monday, January 27th, after market close. The consensus EPS Estimate is $1.33 (+12.7% Y/Y) and the consensus Revenue Estimate is $801.14M (+5.9% Y/Y). Over the last 2 years, PKI has beaten EPS estimates 75% of t...
So far, stock market tailwinds because of end of year bonuses, retirement plan contributions, and institutional re-positioning have offset data suggesting the market is overbought. However, a 3% to 5% correction is getting more likely as the rally broadens out (excluding energy), suggesting in...
The following slide deck was published by PerkinElmer, Inc. in conjunction with this Read more ...
In a strong market for life sciences, a market that has seen Sartorius ( SARTF ) jump more than 70% over the past year, Bio-Rad ( BIO ) more than 60% over the past year, and Thermo Fisher ( TMO ) over 45%, PerkinElmer 's ( PKI ) almost 30% climb doesn't seem quite so special. Part of th...
NuVasive (NASDAQ: NUVA ) initiated with Buy rating and $93 (19% upside) price target at SunTrust. More news on: NuVasive, Inc., OrthoPediatrics Corp., PerkinElmer, Inc., Healthcare stocks news, Stocks on the move, , Read more ...
PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that on Monday, January 27, 2020, after market close, the Company will release fourth quarter 2019 results. The Company will also host a conference call the same day at 5:00 p.m. ET...
10x Genomics (NASDAQ: TXG ) initiated with Buy rating and $100 (32% upside) price target at Citigroup. More news on: 10x Genomics, Inc., AbbVie Inc., AdaptHealth Corp., Healthcare stocks news, Stocks on the move, , Read more ...
We Are Selling Off Temporarily, But Still in a Larger Rally. As Scary as All This Talk of War Is, It Will Blow Over I made a case for the temporary nature of this sell-off on Friday. Rarely does even an actual war directly create a bear market condition, let alone a single drone strike. ...
Historically, These Geopolitical Actions Don’t Cause Extended Sales These are the times that the cash I have been bugging you to create is going to come in very handy. That slug of cash, hopefully, 25% of your trading budget, can now be deployed to take advantage. I would advise n...
News, Short Squeeze, Breakout and More Instantly...
Revenue of $675 million; (30)% reported growth; (27)% organic growth; 6% non-COVID organic growth GAAP EPS of $4.50; Adjusted EPS from continuing operations of $1.01 Updates full year 2023 guidance Authorizes new $600 million share repurchase program To begin tradi...
Transformation aimed at revolutionizing next generation scientific breakthroughs that solve the world’s greatest health challenges Trusted partner to pharma, government and diagnostics customers with complete, end-to-end solutions To begin trading as RVTY under new name on ...
2023-05-07 19:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...